Patent assignee · US · COMPANY

BioXcel Therapeutics, Inc.

🏢 View company profile →
17Patents
17Active
17Granted
59Portfolio score

Filing activity: Dec 29, 2017 → Mar 8, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US10792246B2 Film formulations containing dexmedetomidine and methods of producing them Human Necessities 18 Active
US11497711B2 Film formulations containing dexmedetomidine and methods of producing them Human Necessities 8 Active
US11517524B2 Film formulations containing dexmedetomidine and methods of producing them Human Necessities 8 Active
US11478422B2 Film formulations containing dexmedetomidine and methods of producing them Human Necessities 8 Active
US11559484B2 Film formulations containing dexmedetomidine and methods of producing them Human Necessities 8 Active
US11786508B2 Use of sublingual dexmedetomidine for the treatment of agitation Human Necessities 4 Active
US11806334B1 Non-sedating dexmedetomidine treatment regimens Human Necessities 3 Active
US11806429B2 Film formulations containing dexmedetomidine and methods of producing them Human Necessities 3 Active
US11839604B2 Use of sublingual dexmedetomidine for the treatment of agitation Human Necessities 2 Active
US11890272B2 Non-sedating dexmedetomidine treatment regimens Human Necessities 1 Active
US12138247B2 Non-sedating dexmedetomidine treatment regimens Human Necessities 0 Active
US12364683B2 Non-sedating dexmedetomidine treatment regimens Human Necessities 0 Active
US11998529B2 Non-sedating dexmedetomidine treatment regimens Human Necessities 0 Active
US11998528B1 Non-sedating dexmedetomidine treatment regimens Human Necessities 0 Active
US11931340B2 Use of sublingual dexmedetomidine for the treatment of agitation Human Necessities 0 Active
US12090140B2 Non-sedating dexmedetomidine treatment regimens Human Necessities 0 Active
US12109196B2 Non-sedating dexmedetomidine treatment regimens Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.